Night Squared’s Colgate-Palmolive CL Stock Holding History

Night Squared’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-67,650	Closed	-$6.15M	–	64
2025 Q2	$6.15M	Buy	+67,650	New	+$6.18M	2.74%	12

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Night Squared's CL Position: Q3 2025 in Review

Night Squared sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 67,650 shares — an estimated $6.15M sold.

Night Squared first reported a position in CL in Q2 2025 and held it in 1 quarter. The position peaked at $6.15M in Q2 2025. 1,843 funds tracked by Wall St. Rank hold CL as of Q3 2025.

Night Squared reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
Night Squared sold 67,650 Colgate-Palmolive shares in Q3 2025, an estimated $6.15M.
Night Squared first reported a position in Colgate-Palmolive in Q2 2025 and held it in 1 quarter.
Night Squared's Colgate-Palmolive position peaked at $6.15M in Q2 2025.
1,843 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Night Squared's 13F filing for Q3 2025, filed 14 Nov 2025.